Dronedarone

For research use only. Not for therapeutic Use.

  • CAT Number: I001599
  • CAS Number: 141626-36-0
  • Molecular Formula: C31H44N2O5S
  • Molecular Weight: 556.77
  • Purity: ≥95%
Inquiry Now

Dronedarone(Cat No.:I001599)is an antiarrhythmic medication used to treat atrial fibrillation (AF) and atrial flutter (AFL). It works by blocking multiple ion channels, including potassium, sodium, and calcium channels, which helps to regulate the heart’s electrical activity and maintain a normal rhythm. Dronedarone is structurally related to amiodarone but is designed to have fewer side effects, particularly less thyroid and lung toxicity. It is commonly prescribed to reduce the risk of hospitalization due to recurrent AF or AFL in patients with stable cardiovascular conditions, offering a safer alternative for long-term management.


Catalog Number I001599
CAS Number 141626-36-0
Synonyms

N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide

Molecular Formula C31H44N2O5S
Purity ≥95%
Target CYP3A/CYP450
Solubility 10 mM in DMSO
Storage Store at -20°C
IUPAC Name N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]methanesulfonamide
InChI InChI=1S/C31H44N2O5S/c1-5-8-12-29-30(27-23-25(32-39(4,35)36)15-18-28(27)38-29)31(34)24-13-16-26(17-14-24)37-22-11-21-33(19-9-6-2)20-10-7-3/h13-18,23,32H,5-12,19-22H2,1-4H3
InChIKey ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
SMILES CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC
Reference

<p style=/line-height:25px/>
<br>[1]. Piccinni C, et al.Trends in antiarrhythmic drug use after marketing authorization of dronedarone: comparison between Emilia Romagna (Italy) and Sweden.Eur J Clin Pharmacol. 2012 Sep 1.
<br>[2]. Benaim G, et al.The emerging role of amiodarone and dronedarone in Chagas disease.Nat Rev Cardiol. 2012 Aug 7.
<br>[3]. Rosman J, et al. Possible Proarrhythmia with Dronedarone.J Cardiovasc Electrophysiol. 2012 Jul 19.
<br>[4]. Kao DP, et al. Proarrhythmic Potential of Dronedarone: Emerging Evidence from Spontaneous Adverse Event Reporting.Pharmacotherapy. 2012 Jun 28.
<br>[5]. Manakshe G, Rao BH.Dronedarone-current status in management of atrial fibrillation.Indian Heart J. 2012 Mar-Apr;64(2):182-6. Epub 2012 Apr 28.
</p>

Request a Quote